Risk Profile Improvements

  • Material Weakness (removed) — Previously disclosed material weakness in finance and accounting resources no longer appears in current filing; remediation status unknown.
  • Going Concern (unchanged) — Substantial doubt about ability to continue as going concern remains disclosed in both periods.
NASDAQ: SNTI Senti Biosciences Holdings, Inc. 10-Q

Senti secures $40M convertible debt with 200% maturity penalty; going concern persists

Filed May 14, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 6, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade SNTI commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.